JAGSONPAL PHARMACEUTICALS (JAGSNPHARM) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1978, Jagsonpal Pharmaceuticals Ltd manufactures and trades pharmaceutical products and active pharmaceutical ingredients[1]

JAGSNPHARMUpdated 31 Aug 2026, 15:08

Jagsonpal Pharmaceuticals

Market Cap

₹1,588Cr.

Current Price

₹241

High / Low

₹265/155

Stock P/E

33.8

ROE17.3%
ROCE22.7%
Book Value₹41.2
Face Value₹2.00
Dividend Yield1.62%

About

Incorporated in 1978, Jagsonpal Pharmaceuticals Ltd manufactures and trades pharmaceutical products and active pharmaceutical ingredients[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days119106100734549252632191822
Inventory Days17624629530716419113412282685851
Days Payable426056545976827666353740
Cash Conversion Cycle252292339325150164777248533933
Working Capital Days6872154149675532593452911
ROCE %5%7%3%-10%9%9%18%20%25%17%23%23%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 15:08


Designed & Shipped by Harshit Bansal